Lonza taps Rockwell to digitize Capsugel manufacturing operations

By Maggie Lynch

- Last updated on GMT

(Image: Getty/okskaz)
(Image: Getty/okskaz)

Related tags Lonza Manufacturing operations Software

Lonza to use Rockwell Automation technology as it digitizes the operations and manufacturing environments at nine of its Capsugel facilities to bring “new levels” of operational efficiency.

The Switzerland-based company will use Rockwell’s PharmaSuite Manufacturing Execution System (MES) software to complete its digitization.

John Genovesi, SVP of enterprise accounts and software at Rockwell Automation, said in a statement: “Digital transformation is bringing new levels of operational efficiency, quality, process automation, and employee productivity to pharmaceutical companies globally.”

Rockwell’s solution, according to the company, was designed to avoid disruptions during high volume periods or ‘just-in-time’ orders for on-demand production.

A Lonza spokesperson told us that this project is in line with its “Go Digital” ​initiative, which will enable electronic batch recording and real-time visibility during processes on the floor at all its manufacturing sites.

Based in Wisconsin, Rockwell will also provide Lonza with access to its FactoryTalk InnovationSuite to enable the biotech to trace products through production down to the individual capsule carton.

Related news

Show more

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Related suppliers

Follow us

Products

View more

Webinars